KR20140137529A - Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof - Google Patents
Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof Download PDFInfo
- Publication number
- KR20140137529A KR20140137529A KR1020130058050A KR20130058050A KR20140137529A KR 20140137529 A KR20140137529 A KR 20140137529A KR 1020130058050 A KR1020130058050 A KR 1020130058050A KR 20130058050 A KR20130058050 A KR 20130058050A KR 20140137529 A KR20140137529 A KR 20140137529A
- Authority
- KR
- South Korea
- Prior art keywords
- essential oil
- livestock
- porcine respiratory
- cinnamon
- antimicrobial composition
- Prior art date
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 47
- 241000894006 Bacteria Species 0.000 title claims abstract description 15
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 10
- 244000080208 Canella winterana Species 0.000 title abstract description 7
- 235000008499 Canella winterana Nutrition 0.000 title abstract description 7
- 229940017545 cinnamon bark Drugs 0.000 title abstract description 7
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 6
- 244000144972 livestock Species 0.000 claims abstract description 35
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 244000052616 bacterial pathogen Species 0.000 claims abstract description 17
- 241000606856 Pasteurella multocida Species 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 239000003674 animal food additive Substances 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 229940051027 pasteurella multocida Drugs 0.000 claims abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 claims description 40
- 235000017803 cinnamon Nutrition 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 24
- 241000606750 Actinobacillus Species 0.000 claims description 12
- 239000004599 antimicrobial Substances 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 230000001717 pathogenic effect Effects 0.000 claims description 4
- 210000002345 respiratory system Anatomy 0.000 claims description 4
- 208000035143 Bacterial infection Diseases 0.000 claims description 3
- 241000723347 Cinnamomum Species 0.000 claims 1
- 235000019730 animal feed additive Nutrition 0.000 claims 1
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 abstract description 9
- 230000003115 biocidal effect Effects 0.000 abstract description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 33
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 239000007788 liquid Substances 0.000 description 14
- 206010057190 Respiratory tract infections Diseases 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 241000282898 Sus scrofa Species 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 230000009036 growth inhibition Effects 0.000 description 8
- 235000013311 vegetables Nutrition 0.000 description 8
- 239000013641 positive control Substances 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 5
- 229940117916 cinnamic aldehyde Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 238000013272 agar well diffusion method Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 244000004281 Eucalyptus maculata Species 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 description 3
- 240000002657 Thymus vulgaris Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000010620 bay oil Substances 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000010642 eucalyptus oil Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- 241001293418 Mannheimia haemolytica Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000606860 Pasteurella Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 241000725681 Swine influenza virus Species 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N beta-linalool Natural products CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000017066 negative regulation of growth Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000030925 respiratory syncytial virus infectious disease Diseases 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- KSRXPHFIPQCQNN-UHFFFAOYSA-N 2-methoxy-4-prop-2-enylbenzaldehyde Chemical compound COC1=CC(CC=C)=CC=C1C=O KSRXPHFIPQCQNN-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241001660917 Crassula ovata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 101100172179 Escherichia coli O78:H11 (strain H10407 / ETEC) eltA gene Proteins 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical group CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 101100481893 Pasteurella multocida toxA gene Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000422846 Sequoiadendron giganteum Species 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 101100006379 Vibrio cholerae chxA gene Proteins 0.000 description 1
- 101100113493 Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) ctxA gene Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000012459 agar diffusion assay Methods 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000000711 cavernous sinus Anatomy 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- 229960004413 flucytosine Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000002956 necrotizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 201000006509 pleuropneumonia Diseases 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 101150032575 tcdA gene Proteins 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
Abstract
Description
본 발명은 돼지 호흡기 복합감염증 원인 세균에 대해 항균활성을 나타내는 계피 정유 및 이의 용도에 관한 것으로, 더욱 상세하게는 계피 정유를 유효성분으로 함유하는 가축 병원성 세균 억제용 항균 조성물, 특히 돼지 호흡기 복합감염증을 유발하는 세균인 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae), 파스투렐라 물토시다(Pasteurella multocida) A 및 파스투렐라 물토시다 D를 억제하는 항균 조성물 및 상기 조성물을 유효성분으로 함유하는 가축 사료첨가제 및 가축사료에 관한 것이다.The present invention relates to a cinnamon essential oil having antimicrobial activity against bacteria causing porcine respiratory infections and more particularly to an antimicrobial composition for inhibiting bacterial pathogenic bacteria containing cinnamon essential oil as an active ingredient, Actinobacillus < / RTI > ( Actinobacillus < RTI ID = 0.0 > pleuropneumoniae , < / RTI > Pasteurella The present invention also relates to an antimicrobial composition for inhibiting a multocida A and a pastelolactone D, and a livestock feed additive and a livestock feed containing the composition as an active ingredient.
돼지 호흡기 복합감염증(PRDC, porcine respiratory disease complex)은 10∼22주령의 주로 육돈 및 비육돈에 발생하며, 발육부진, 사료효율 저하, 무기력, 식욕부진, 발열, 기침, 호흡장애를 특징으로 한다. 돼지 호흡기 복합감염증은 돼지 호흡기 생식기 증후군 바이러스(PRRSV), 돼지 인플루엔자바이러스(SIV), 가성광견병바이러스(pseudorabies virus), 미코플라스마 하이오뉴모니애(Mycoplasma hyopneumoniae), 액티노바실러스 플루로뉴모니애(Actinobacilus pleurpneumoniae) 및 파스투렐라 물토시다(Pasteurella Multocida) 등의 혼합감염에 의해 발생하며, 이들 원인체들 중 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae) 및 파스투렐라 물토시다(P. Multocida)는 돼지 호흡기 복합감염증의 1차 감염균인 동시에 2차 감염으로 심각한 증상을 일으킨다. 액티노바실러스 플루로뉴모니애는 급성 및 만성 경과를 취하는 돼지흉막 폐렴의 원인균으로 섬유소성 흉막염, 출혈성 괴사성 병변을 동반한다. 이 균에 의한 호흡기전염병은 환경이 불량하거나 밀집 사육 상태에서 흔히 발병되며, 이 병에 감염된 돼지는 폐사를 비롯한 발육지연과 사료효율의 저하를 가져와 양돈업에 많은 경제적 손실을 주는 질병이다. 이 균은 돼지의 호흡기에 제 1차 감염균으로 작용하며, 한 동물당 104~105개의 균을 정맥 내로 인공감염시 폐사하며, 103개의 균을 정맥 내로 주사시 만성감염병 경과를 취한다고 한다. 파스투렐라 물토시다는 돼지에서 호흡기내의 상재균인 동시에 호흡기 질환을 유발하는 병원체로서, 그람음성균으로 협막의 혈청형에 따라 A, B, D, E 및 F 형으로 분류된다. 145kDa의 독성 단백질을 암호화하는 toxA 유전자의 존재에 따라 독성이 결정이 되며 주로 A형이나 D형에서 나타나는 경향이 있다. A형은 돼지, 소 및 닭에서 기관지 폐렴을, B형은 소에서 출혈성 패혈증을, D형은 돼지에서 위축성비염(atropicrhinitis; AR)을 일으키는 것으로 알려져 있다.PRDC (porcine respiratory disease complex) is a disease characterized by poor growth, poor feed efficiency, lethargy, anorexia, fever, cough, and respiratory distress, occurring mainly in stock and finishing pigs between 10 and 22 weeks of age. Porcine respiratory syncytial virus infection can be caused by a variety of diseases including porcine respiratory syndrome virus (PRRSV), swine influenza virus (SIV), pseudorabies virus, Mycoplasma hyopneumoniae , Actinobacillus pleurpneumoniae and Pasteurella < RTI ID = 0.0 > Multicida ), among them, Actinobacillus A. pleuropneumoniae and P. multocida are the primary infectious agents of porcine respiratory syncytial virus infection Secondary infections cause severe symptoms. Actinobacillus pneumoniae is a causative organism of acute and chronic pneumothorax. It is associated with fibrosing pleurisy and haemorrhagic necrotizing lesions. The respiratory infectious disease caused by this bacterium is often caused by a poor environment or a dense breeding condition, and pigs infected with this disease cause a delay in development including mortality and a decrease in feed efficiency, thereby causing a great economic loss to the pigs. This strain acts as a primary infectious organism in the respiratory system of pigs. It is said that 10 4 to 10 5 bacteria per animal are killed intravenously during artificial infection, and 10 3 microorganisms are injected intravenously to take chronic infection . Pasteurla La Mortosida is a pathogen in the swine of the respiratory tract that induces respiratory disease. It is classified as A, B, D, E and F according to the serotype of the cavernous sinus. The toxicity is determined by the presence of the toxA gene, which encodes a 145 kDa toxin protein, and is predominantly expressed in type A or type D. Type A is known to cause bronchopneumonia in pigs, cattle, and chickens, hemorrhagic sepsis in cattle in type B, and atropic rhinitis (AR) in pigs.
돼지 호흡기 질병은 불현성 감염 또는 만성으로 내과하는 경우가 많으므로 양돈농가에서 병의 심각성을 제대로 알기란 쉽지 않으며, 현대의 양돈산업의 대규모화로 인해 돼지 호흡기 질병의 발생 가능성은 점점 증가되고 있으며, 이의 방제는 더욱 어려운 실정이다. 현재 가축에서의 항생제 및 항균제 사용은 축산물의 안전성 문제로 인해 규제가 날로 강화되고 있으며 특히 배합사료에 첨가되는 항생제 사용규제가 향후 더욱 강화될 것으로 보이며, 잔류검사 강화로 축산 농가들도 휴약 기간이 긴 항생제 사용을 기피하고 있다. 또한 항생제의 남용으로 항생제 내성 병원균들이 나타남으로써 대체 항균 물질의 개발이 필요한 상황이다.It is not easy to know the severity of disease in swine farms because swine respiratory diseases are often infectious or chronic. Therefore, the possibility of swine respiratory disease is increasing due to the large scale of modern swine industry. Is more difficult. Currently, the use of antibiotics and antibiotics in livestock is being strengthened due to the safety issue of livestock products. In particular, regulations on the use of antibiotics added to compound feeds will be strengthened in the future. Avoiding the use of antibiotics. In addition, the abuse of antibiotics causes the development of antibiotic resistant pathogens.
최근, 친환경 항생제 대체제에 대한 연구가 다양한 분야에서 이루어지고 있으며, 크게 병원성 미생물에 대하여 직접적인 길항작용을 나타내는 유용 미생물들을 중심으로 한 생균제(Probiotics) 분야와 식물자원 및 기타 천연물질로부터 항균활성을 나타내는 물질을 개발하여 상용화하는 추출물 분야가 있다. 식물자원에 존재하는 다양한 병원성 미생물에 대한 항균활성을 나타내는 항균성 물질을 항균소재로 이용하고자 하는 연구는 식품, 의약 및 생물공학산업 등에서 오래전부터 활발하게 연구되어 오고 있으며(Shin. D.H et al., 1997. Korean J. Food SCI. TECHNOL. 29:808-816), 다양한 식물자원중 향료 식물(herbs)은 직접적인 항균활성 기능뿐만 아니라 수많은 생리활성물질(bioactive chemical compounds)과 비타민, 칼슘 및 철분 등의 다양한 영양소를 가지고있어 질병예방 및 치료에 적용되어 왔다. 특히 인삼, 향 아카시아, 쑥, 국화, 꽃창포, 구절초, 장미, 백일초, 천일홍, 계피나무, 향나무, 유자, 탱자 등의 향료식물들은 생리활성 기능이 우수하여 널리 이용되어오고 있다.Recently, researches on environmentally friendly antibiotic substitutes have been carried out in various fields. In particular, researches on probiotics using useful microorganisms showing direct antagonistic action against pathogenic microorganisms and materials showing antimicrobial activity from plant resources and other natural substances Has been developed and commercialized. Studies using antimicrobial agents, which exhibit antimicrobial activity against various pathogenic microorganisms present in plant resources, as antimicrobial materials have been actively studied in food, medicine, and biotechnology industries for a long time (Shin et al., 1997 , J. Food SCI. TECHNOL. 29: 808-816), herbicides of various plant sources have not only a direct antimicrobial activity but also various bioactive chemical compounds and a variety of vitamins, calcium and iron It has nutrients that have been applied to the prevention and treatment of diseases. Especially, spice plants such as ginseng, incense acacia, wormwood, chrysanthemum, iris, rhododendron, rosemary, rhododendron, cinnamon, cinnamon, juniper, citron and tangja have excellent physiological activity and are widely used.
이 중, 계피는 우리나라에서 녹나무과의 육계(Cinnamomum cassia Blume) 또는 동속 근연식물의 수피 또는 주피를 다소 제거한 수피를 말하는 것으로, 옥계 또는 대계 등으로도 불리며, 산지는 주로 중국의 남부, 일본 남부, 베트남, 캄보디아, 태국 등지로 우리나라산 계피는 중국에서 이식된 것이며 과자, 음료 등의 향료 및 한약재로서 오래전부터 사용되어 온 식물자원이다. 계피(cinnamon bark)에는 탄닌과 정유(essential oil) 성분의 대부분을 차지하는 신남 알데히드(cinnamic aldehyde), 신남산(cinnamic acid) 등이 함유되어 있으며, 계피유는 계피를 증류한 유상의 물질로서 특유한 향기 및 감미와 신미가 많다. 계피의 약리작용으로는 개선균 억제작용, 백색염주균병 억제작용, 건위작용, 타액 및 위액 분비촉진작용 등이 보고되었으며, 약효 성분은 휘발성 정유 성분이 약 1%인데, 그 중에 펠란드렌(Phellandrene), 유게놀(Eugenal), 메칠유게놀(Methyleugual) 등이 함유되어 있다.Among them, cinnamon is the most common cinnamomum cassia Blume is a kind of bark in which the bark or juniper of a relative plant is removed to some extent. It is also referred to as a jade tree or a big tree. The mountainous region is mainly southern China, southern Japan, Vietnam, Cambodia, Thailand, And it is a plant resource that has been used for a long time as a spice such as confectionary, drink, and herb medicine. Cinnamon bark contains cinnamic aldehyde and cinnamic acid, which are the major components of tannin and essential oil. Cinnamon oil is an oily matter which is distilled from cinnamon. There is a lot of sweetness and sincerity. The pharmacological actions of cinnamon have been reported as improving bacteria inhibiting action, inhibition of white spore strain, actinic action, saliva and gastric secretion promoting action, and the active ingredient is volatile essential oil component of about 1%. Phellandrene ), Eugenal, Methyleugual, and the like.
한편, 한국공개특허 제2003-0031331호에는 '계피 추출물을 함유하는 항진균 및 살충제 조성물'이 개시되어 있고, 한국등록특허 제693077호에는 '돼지 복합 호흡기 질환 예방 및 치료용 생물학적 조성물'이 개시되어 있으나, 본 발명의 돼지 호흡기 복합감염증 원인 세균에 대해 항균활성을 나타내는 계피 정유 및 이의 용도에 대해서는 기재된 바가 없다.Korean Patent Publication No. 2003-0031331 discloses 'antifungal and insecticidal composition containing cinnamon extract', Korean Patent No. 693077 discloses 'biological composition for prevention and treatment of porcine combined respiratory disease' , The cinnamon essential oil showing antimicrobial activity against the bacteria causing the porcine respiratory tract infection of the present invention and its use are not described.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 천연 식물로부터 얻은 휘발성 정유들 중 특히 계피 정유를 돼지 호흡기 복합감염증을 유발하는 원인균인 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae), 파스투렐라 물토시다(Pasteurella multocida) A 및 파스투렐라 물토시다 D에 처리한 결과, 계피 정유가 상기 병원성 세균들의 생육을 강하게 억제하는 항균활성을 나타내는 것을 확인함으로써 본 발명을 완성하였다.SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and it is an object of the present invention to provide a method for the production of actinobacillus flucytosine pleuropneumoniae , < / RTI > Pasteurella multocida A and pasturella mushroom D, the present inventors completed the present invention by confirming that cinnamon essential oil exhibits antimicrobial activity strongly inhibiting the growth of the pathogenic bacterium.
상기 과제를 해결하기 위해, 본 발명은 계피 정유(cinnamon bark essential oil)를 유효성분으로 함유하는 가축 병원성 세균 억제용 항균 조성물을 제공한다.In order to solve the above problems, the present invention provides an antimicrobial composition for inhibiting bacterial pathogenic bacteria containing cinnamon bark essential oil as an active ingredient.
또한, 본 발명은 상기 가축 병원성 세균 억제용 항균 조성물을 가축에 처리하는 단계를 포함하는 것을 특징으로 하는 가축의 병원성 세균 유래 질병의 예방 또는 치료방법을 제공한다.The present invention also provides a method of preventing or treating pathogenic bacterial diseases caused by livestock, which comprises treating the above-mentioned antimicrobial composition for inhibiting livestock pathogenic bacteria.
또한, 본 발명은 상기 계피 정유를 함유하는 가축 병원성 세균 억제용 항균 조성물을 유효성분으로 함유하는 가축 사료첨가제 및 가축사료를 제공한다.In addition, the present invention provides a livestock feed additive and a livestock feed containing an antimicrobial composition for inhibiting bacterial pathogenic bacteria containing the cinnamon essential oil as an active ingredient.
본 발명에서 계피 정유는 돼지 호흡기 복합감염증을 유발하는 원인균들에 대해 강한 항균활성을 나타내어, 새로운 항생제 대체물질로의 가능성을 확인하였다. 따라서, 본 발명의 계피 정유는 대체 항생제로서 가축의 질병 예방 및 치료에 활용할 수 있으므로 산업적으로 매우 유용하게 이용될 수 있다.In the present invention, cinnamon essential oil showed a strong antimicrobial activity against causative microorganisms causing porcine respiratory infections, confirming the possibility of a new antibiotic substitute. Therefore, the cinnamon essential oil of the present invention can be used as an alternative antibiotic for the prevention and treatment of diseases of livestock, and thus can be very useful industrially.
도 1은 계피 정유의 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae)에 대한 항균활성을 측정한 한천 웰 확산법(agar well diffusion method)의 결과로, 계피 정유를 포함하고 있는 웰 주변의 콜로니의 성장이 억제된 것을 보여준다. DMSO; 음성 대조군, Ampicillin; 양성 대조군.1 is of the well close to that contain cinnamon essential oil as a result of the agar-well diffusion method (agar well diffusion method) Measurement of antibacterial activity against pneumoniae in liquid Martino Bacillus flu cinnamon essential oil (A. Pleuropneumoniae) colonies Growth was suppressed. DMSO; Negative control, Ampicillin; Positive control.
본 발명의 목적을 달성하기 위하여, 본 발명은 계피 정유(cinnamon bark essential oil)를 유효성분으로 함유하는 가축 병원성 세균 억제용 항균 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides an antimicrobial composition for inhibiting bacterial pathogenic bacteria containing cinnamon bark essential oil as an active ingredient.
"항균 (antimicrobial)"의 의미는 어떤 농도에서 미생물의 성장 또는 생존을 감소, 방지, 억제, 또는 제거하는 능력을 의미한다.By "antimicrobial" is meant the ability to reduce, prevent, inhibit, or eliminate microbial growth or survival at any concentration.
본 발명의 "함유하는 (comprising)" 용어는 포함하는 것에 한정되지 않으며, 일예로 다른 첨가제, 성분, 지수 또는 단계와 같은 것을 제외하지 않는다.The term " comprising "of the present invention is not limited to inclusive, and does not exclude, for example, other additives, ingredients, exponents, or steps.
상기 본 발명의 가축 병원성 세균 억제용 항균 조성물의 계피 정유는 용매 추출법, 초임계 이산화탄소 추출법 또는 수증기 증류법으로 추출된 것일 수 있으나, 이에 제한하지 않는다.The cinnamon essential oil of the antimicrobial composition for inhibiting bacterial pathogenic bacteria of the present invention may be one extracted by a solvent extraction method, a supercritical carbon dioxide extraction method or a steam distillation method, but is not limited thereto.
상기 본 발명의 가축 병원성 세균은 돼지 호흡기 복합감염증(Porcine Respiratory Disease Complex)을 유발하는 세균으로, 맨하이미아 해모리티카(Mannheimia haemolytica), 해모필러스 솜너스(Haemopilus somnus), 파스투렐라 물토시다(Pasteurella multocida), 마이코 플라즈마(Mycoplasma hyopneumoniae) 또는 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae)일 수 있고, 바람직하게는 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae), 파스투렐라 물토시다(Pasteurella multocida) A 또는 파스투렐라 물토시다 D 일 수 있으나, 이에 제한하지 않는다.The livestock pathogenic bacterium of the present invention is a bacterium that induces Porcine Respiratory Disease Complex, which is called Mannheimia haemolytica ), Haemopilus somnus , Pasteurella multocida , Mycoplasma hyopneumoniae or Actinobacillus < RTI ID = 0.0 > pleuropneumoniae ), preferably Actinobacillus < RTI ID = 0.0 > pleuropneumonia e), Pasteurella multocida A, or passthrough, but is not limited thereto.
본 발명은 또한, 계피 정유를 유효성분으로 함유하는 가축 세균 억제용 항균 조성물을 가축에 처리하는 단계를 포함하는 것을 특징으로 하는 가축의 병원성 세균 유래 질병의 예방 또는 치료방법을 제공한다.The present invention also provides a method for preventing or treating pathogenic bacterial diseases caused by livestock, which comprises treating a livestock with an antimicrobial composition for controlling livestock bacterium containing cinnamon essential oil as an active ingredient.
본 발명의 방법에서, 상기 가축 세균 억제용 항균 조성물을 가축에 처리하는 단계는 가축 축사에서 분무 또는 기화시키는 것일 수 있으나, 이에 제한하지 않는다.In the method of the present invention, the step of treating the livestock with the antimicrobial composition for inhibiting livestock bacterium may be spraying or vaporizing in a livestock farm, but is not limited thereto.
본 발명의 일 구현 예에 따른 방법에서, 상기 가축은 소, 닭, 돼지, 말, 염소, 오리, 거위, 개, 고양이 또는 토끼일 수 있으며, 바람직하게는 돼지일 수 있으나, 이에 제한하지 않는다.In a method according to an embodiment of the present invention, the animal may be a cow, a chicken, a pig, a horse, a goat, a duck, a goose, a dog, a cat or a rabbit, and preferably a pig.
본 발명의 방법에서, 상기 가축 병원성 세균은 돼지 호흡기 복합감염증(Porcine Respiratory Disease Complex)을 유발하는 세균으로, 맨하이미아 해모리티카(Mannheimia haemolytica), 해모필러스 솜너스(Haemopilus somnus), 파스투렐라 물토시다(Pasteurella multocida), 마이코 플라즈마(Mycoplasma hyopneumoniae) 또는 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae)일 수 있고, 바람직하게는 액티노바실러스 플루로뉴모니애(Actinobacillus pleuropneumoniae), 파스투렐라 물토시다(Pasteurella multocida) A 또는 파스투렐라 물토시다 D 일 수 있으나, 이에 제한하지 않는다.In the method of the present invention, the livestock pathogenic bacterium is a bacterium that induces Porcine Respiratory Disease Complex, which is Mannheimia haemolytica ), Haemopilus somnus , Pasteurella multocida), mycoplasma (Mycoplasma hyopneumoniae) or liquid Martino Bacillus flu in pneumoniae (Actinobacillus pleuropneumoniae) may be, and preferably liquid Martino Bacillus flu in pneumoniae (Actinobacillus pleuropneumonia e, Pasteurella multocida A, or Passthrough la water D, but not limited thereto.
본 발명은 또한, 계피 정유를 함유하는 가축 세균 억제용 항균 조성물을 유효성분으로 함유하는 가축 사료첨가제 및 가축사료를 제공한다.The present invention also provides a livestock feed additive and a livestock feed containing as an active ingredient an antimicrobial composition for controlling livestock bacteria containing cinnamon essential oil.
본 발명의 상기 가축 사료첨가제는 원형 그대로 사용하거나 또는 추가적으로 가축에 허용되는 곡류 및 그 부산물 등의 공지된 담체, 안정제 등을 가할 수 있으며, 필요에 따라 구연산, 후말산, 아디픽산, 젖산, 사과산 등의 유기산이나 인산나트륨, 인산칼륨, 산성 피로인산염, 폴리인산염(중합인산염) 등의 인산염이나, 폴리페놀, 카테킨, 알파-토코페롤, 로즈마리 추출물, 비타민 C, 녹차 추출물, 감초 추출물, 키토산, 탄닌산, 피틴산 등의 천연 항산화제, 항생물질, 항균제 및 기타의 첨가제 등을 가할 수도 있으며, 그 형상으로서는 분체, 과립, 펠릿, 현탁액 등의 적당한 상태일 수 있으며, 상기 사료첨가제를 공급하는 경우는 가축 등에 대하여 단독으로 또는 사료에 혼합하여 공급할 수 있다.The livestock feed additive of the present invention can be used as it is in its original form, or additionally, known carriers such as cereal grains and by-products thereof, stabilizers and the like can be added, and if necessary, citric acid, fumaric acid, adipic acid, lactic acid, Such as polyphosphoric acid, catechin, alpha-tocopherol, rosemary extract, vitamin C, green tea extract, licorice extract, chitosan, tannic acid, phytic acid (phosphoric acid) Antibiotics, antimicrobial agents, and other additives may be added. The shape of the powder may be a proper state such as powder, granule, pellet, suspension, etc. When the feed additive is supplied, Or mixed with feed.
본 발명에서 가축사료를 제조하는 경우, 첨가제는 곡류, 예를 들면 연마되거나 분쇄된 밀, 귀리, 보리, 옥수수 및 쌀; 평지씨, 대두콩 및 해바라기 씨에 근거한 식물성 단백질 공급원; 동물성 단백질 공급원; 당밀; 및 우유 제품, 예를 들면 다양한 우유 분말 및 유장 분말로 구성된 건조 성분과 혼합될 수 있다. 모든 건조 성분과 혼합된 후, 액체 성분 및 가열 후 액체가 된 성분을 첨가할 수 있다. 액체 성분은, 선택적으로 가열에 의해 액화된 지질, 예를 들면 지방, 예를 들면 식물성 지방, 및/또는 카복실산, 예를 들면 지방산으로 구성될 수 있다. 완전히 혼합한 후, 성분의 연마도에 따라 가루 또는 입자상 농도가 수득된다. 저장하는 동안 분리되는 것을 방지하기 위해서, 물을 바람직하게는 동물 사료에 첨가해야만 하고, 이 사료는 후속적으로 종래의 펠렛화, 증량 또는 압출 공정으로 처리된다. 임의의 추가의 물을 건조에 의해 제거할 수 있다. 원하는 경우, 생성된 입자상 동물 사료를 더 작은 입자 크기로 분쇄할 수 있다.When preparing livestock feeds in the present invention, the additive may be selected from cereal crops such as ground or grinded wheat, oats, barley, corn and rice; Vegetable protein sources based on rapeseed, soybean and sunflower seeds; An animal protein source; molasses; And milk products, such as various milk powders and whey powders. After mixing with all the dry ingredients, the liquid ingredients and the ingredients that become liquid after heating can be added. The liquid component may optionally consist of lipids liquefied by heating, for example fats, for example vegetable fats, and / or carboxylic acids, for example fatty acids. After thorough mixing, a powder or particulate concentration is obtained depending on the degree of polishing of the component. In order to prevent separation during storage, water should preferably be added to the animal feed, which is subsequently treated with conventional pelletization, extrusion or extrusion processes. Any additional water can be removed by drying. If desired, the resulting particulate animal feed can be pulverized into smaller particle sizes.
본 발명의 일 구현 예에 따른 가축 사료첨가제 및 가축사료에서, 상기 가축은 바람직하게는 소, 닭, 돼지, 말, 염소, 오리, 거위, 개, 고양이 또는 토끼이며, 더욱 바람직하게는 돼지일 수 있으나, 이에 제한하지 않는다.
In a livestock feed additive and a livestock feed according to an embodiment of the present invention, the livestock is preferably a cow, a chicken, a pig, a horse, a goat, a duck, a goose, a dog, a cat or a rabbit, But is not limited thereto.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
실시예Example 1. 식물성 정유의 항균활성 측정 1. Antimicrobial activity measurement of vegetable essential oil
일반적인 항균활성 측정 방법에는 한천 확산법(agar diffusion assay)을 사용한다. 한천 확산법에는 종이 디스크(paper disc) 방법과 한천 웰(agar well) 방법 두 가지 방법이 있으며, 원리는 항균활성을 지니는 물질이 한천 속으로 확산 되어 그로 인해 나타나는 생육저해환(clear zone)의 크기로 항균활성을 결정하는 것으로, 종이 디스크 방법의 경우 디스크에 항균 물질이 응축되거나 휘발할 수 있는 단점이 있다. 이에 식물성 정유 성분의 항균활성 측정에 있어 종이 디스크 방법과 한천 웰 방법 두 가지 방법으로 항균활성을 측정하여 비교한 결과, 한천 웰 방법이 종이 디스크 방법보다 더 적합한 방법이라고 판단되어 한천 웰 방법으로 실험을 진행하였다.Agar diffusion assay is used for general antimicrobial activity measurement method. There are two methods of agar diffusion method: paper disc method and agar well method. The principle is that the material having antimicrobial activity diffuses into the agar and the size of the clear zone In the case of the paper disk method, there is a disadvantage that the antimicrobial substance may be condensed or volatilized on the disk. As a result of comparing antimicrobial activities by two methods of paper disk method and agarwel method in measuring the antimicrobial activity of vegetable essential oil component, it was concluded that the agarwel method is more suitable than the paper disk method, .
총 14개의 식물성 정유를 구입하여 1차적으로 한천 웰 확산법으로 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae)에 대한 항균활성을 측정하였다. 액티노바실러스 플루로뉴모니애 균주 배양액(O.D.600=0.5~0.6) 100㎕를 TSB 한천 배지 표면에 균일하게 도말한 후, 플레이트 표면에 웰을 만들었다. 이 웰에 식물성 정유와 지표물질을 각 50㎕씩 첨가하고, 30℃에서 24시간 동안 배양하여 관찰하였다. 한천 웰 주위로 지시균주들의 생장이 저해되는 생육저해환의 직경을 측정하여 항균활성의 크기를 나타내었다. 항생제 암피실린(ampicillin) 1㎎/㎖을 양성 대조군으로 사용하였다. 항균활성을 측정한 결과는 표 1과 같다.Antibacterial activity against pneumoniae (A. Pleuropneumoniae) to purchase and a total of 14 vegetable oil refining with liquid Martino Bacillus flu by the agar-well diffusion method as a primary measure. Actino Bacillus fluroneumoniae 100 占 퐇 of the culture medium of the strain (OD 600 = 0.5 to 0.6) was uniformly plated on the surface of the TSB agar medium and wells were formed on the surface of the plate. 50 쨉 l of vegetable essential oil and indicator material were added to each well and cultured at 30 째 C for 24 hours. The diameters of growth inhibition rings inhibited the growth of the indicated strains around the agar well, and the magnitude of the antimicrobial activity was shown. 1 mg / ml of antibiotic ampicillin was used as a positive control. The results of the antimicrobial activity measurements are shown in Table 1.
계피(Cinnamon bark)와 타임(thyme) 정유는 다른 14개의 식물성 정유 중 양성 대조군과 동일한 15㎜ 크기의 생육저해환을 보여 가장 뛰어난 항균력을 보였다. 유칼립투스(Eucalyptus)와 베이(bay) 정유는 두 번째로 높은 10㎜ 크기의 생육저해환이 생성되었다. 나머지 10개의 식물성 정유들은 액티노바실러스 플루로뉴모니애에 대한 생육저해환이 1~5㎜ 정도의 크기로, 항균활성은 가지나 양성 대조군과 계피, 타임, 유칼립투스 및 베이 정유보다는 항균활성이 뛰어나지 않은 것으로 확인되었다.
Cinnamon bark and thyme essential oil showed the best antimicrobial activity in the other 14 vegetable essential oils, showing the same inhibitory growth inhibition size of 15 mm as the positive control. Eucalyptus and bay essential oil produced the second highest growth inhibition size of 10 mm. The remaining 10 vegetable essential oils have an antimicrobial activity of about 1 to 5 mm in inhibition of growth on Actinobacillus fluroxenone, but are not superior in antibacterial activity to positive control, cinnamon, thyme, eucalyptus and bay oil .
실시예Example 2. 식물성 정유의 저해농도 측정 2. Inhibitory concentration measurement of vegetable essential oil
정유 원액으로 실험한 결과를 토대로 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae) 균에 대해 항균활성이 우수한 계피, 타임, 유칼립투스 및 베이 정유의 저해농도(inhibitory concentration)를 측정하였다. 상기 식물성 정유를 1/10씩 1~100000ppm까지 DMSO(dimethyl sulfoxide, St. Louis, MO, USA)로 희석하여 한천 웰 확산법으로 저해농도를 측정하였다. 희석에 사용한 DMSO를 음성 대조군으로 사용하였고, 항생제 암피실린을 양성 대조군으로 사용하였다. 측정한 결과는 표 2와 같다.A liquid Martino Bacillus flu pneumoniae in (A. Pleuropneumoniae) bacteria inhibitory concentrations (inhibitory concentration) in the fine cinnamon, thyme, bay essential oil of eucalyptus and the antimicrobial activity for on the basis of the results of experiments in oil refining raw liquid was measured. The vegetable essential oil was diluted 1 to 100000 ppm with 1/10 dilution of DMSO (dimethyl sulfoxide, St. Louis, Mo., USA) and the inhibitory concentration was measured by an agar well diffusion method. DMSO used for dilution was used as a negative control, and antibiotic ampicillin was used as a positive control. The results are shown in Table 2.
100000ppm 농도의 경우, 계피 정유는 희석하지 않은 원액과 같은 15㎜의 생육저해환의 크기를 나타내었고, 타임 정유는 원액보다는 작은 10㎜의 생육저해환을 보였으며, 유칼립투스 및 베이 정유의 경우는 원액의 크기보다 약 1/2 정도 줄어든 6㎜ 및 3㎜ 크기의 생육저해환을 나타내었다. 10000ppm 농도에서는 계피 정유는 원액의 크기보다 약 1/3 정도 줄어든 5㎜의 생육저해환을 보였고, 타임 정유는 원액보다 약 1/5 줄어든 2㎜의 생육저해환을 생성하였으며, 유칼립투스 및 베이 정유는 10000ppm 농도에서는 생육저해환을 생성하지 않았다. 1000ppm 이하의 농도에서는 상기 4가지 모든 식물성 정유에서 생육저해환을 생성하지 않아, 항균활성을 보이지 않음을 확인하였다.
In the case of 100000ppm concentration, cinnamon essential oil showed the size of growth inhibition ring of 15 mm same as undiluted undiluted solution, and time essential oil showed growth inhibition ring of 10 mm smaller than undiluted solution. In case of eucalyptus and bay oil, And 6 mm and 3 mm in size, respectively. At the concentration of 10000ppm, cinnamon essential oil showed growth inhibition of 5 mm, which was about 1/3 less than the original solution. Time essential oil produced a growth inhibition ring of 2 mm, which was about 1/5 smaller than the undiluted solution. Eucalyptus and bay oil At the concentration of 10000 ppm, no inhibition of growth was observed. It was confirmed that no inhibitory effect on growth inhibition was observed in all of the four vegetable essential oils at a concentration of 1000 ppm or less, indicating no antimicrobial activity.
실시예Example 3. 계피 정유의 최소저해농도 측정 3. Measurement of minimum inhibitory concentration of cinnamon essential oil
한천 웰 확산법과 저해농도 측정의 결과 우수한 항균활성을 보인 계피 정유의 액티노바실러스 플루로뉴모니애 외 다른 돼지 호흡기 복합감염증 원인균들인 파스투렐라 물토시다 A 및 파스투렐라 물토시다 D에 대한 최소저해농도(Minimum Inhibitory Concentration, MIC)를 측정하였다.Actinobacillus pluropneumoniae of cinnamon essential oil, which showed excellent antimicrobial activity as a result of agar diffusion method and inhibition concentration measurement, A and the minimum inhibitory concentration (MIC) for the passthrough la Water Soda D were measured.
먼저 DMSO를 사용하여 계피 정유를 희석하여 TSB 및 BHI 액체 배지에 첨가하고, 전체 볼륨은 3㎖로 맞춰서 측정하였으며, 각각의 균주를 배양액에 접종한 후, 30℃에서 24시간 배양하고 관찰하였다. 최소저해농도 분석은 액체 배지 희석법(broth dilution method)을 변형하여 수행하였다. 음성 대조군으로 DMSO를 사용하였고, 항생제 암피실린을 양성 대조군으로 사용하였다. 최소저해농도를 측정한 결과는 표 3과 같다.First, the cinnamon essential oil was diluted with DMSO and added to TSB and BHI liquid medium. The total volume was adjusted to 3 ml. Each strain was inoculated into the culture medium and cultured at 30 ° C for 24 hours. Minimal inhibition concentration analysis was performed by modifying the broth dilution method. DMSO was used as a negative control, and ampicillin was used as a positive control. Table 3 shows the results of measuring the minimum inhibitory concentration.
계피 정유는 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae)에 대해 100ppm 농도에서 최소저해활성을 보였고, 파스투렐라 물토시다(P. multocida) A와 D에 대해서는 각각 50ppm과 60ppm의 농도에서 최소저해활성을 보임을 확인하였다. 상기 한천 웰 확산법으로 저해농도를 측정한 결과 보다 액체 배지 희석법으로 측정한 결과가 더 뛰어난 활성을 나타내는 것으로 확인되었으며, 이는 항균물질의 확산이 고체인 한천보다는 액체 배지에서 더 잘되기 때문인 것으로 생각된다.
Cinnamon essential oil is a liquid Martino showed minimal inhibitory activity in the Bacillus flu 100ppm concentration for pneumoniae (A. Pleuropneumoniae) in the water Toshima, paseuturel La (P. multocida) A and D showed the minimum inhibitory activity at concentrations of 50ppm and 60ppm, respectively. It was confirmed that the result obtained by the liquid medium dilution method shows better activity than the result of measuring the inhibition concentration by the above agar diffusion method. This is because diffusion of the antimicrobial substance is better in the liquid medium than solid agar.
실시예Example 4. 계피 정유의 주요성분 최소저해농도 측정 4. Determination of the minimum inhibitory concentration of essential components of cinnamon essential oil
계피 정유의 어떤 성분에 의해서 액티노바실러스 플루로뉴모니애(A. pleuropneumoniae)와 파스투렐라 물토시다(P. multocida) A 및 D의 생육이 저해되는지 알아보기 위해 계피 정유의 주요성분에 대해서 최소저해농도를 측정해보았다. 계피 정유의 성분은 신남알데하이드(cinnamaldehyde)가 90% 이상으로 구성되어 있고, 나머지는 에틸 신나메이트(ethyl cinnamate), 유게놀(eugenol, 일반적으로 잎에 있음), 베타 캐리오필렌(beta-caryophyllene), 리날룰(linalool) 및 메틸 차비콜(methyl chavicol) 등이 있다. 계피 정유의 주요성분으로 실험에 사용한 성분은 신남알데하이드(cinnamaldehyde)이며, 이 성분은 시그마 알드리치(St. Louis, MO, USA)에서 구입하였다. 측정 방법은 상기 계피 정유의 최소저해농도 측정과 동일한 방법으로 액체 배지 희석법을 변형하여 수행하였으며, 음성 대조군으로 DMSO를, 양성 대조군으로 항생제 암피실린을 사용하였으며, 측정 결과는 표 4와 같다.Certain ingredients of cinnamon essential oil are known to be effective against A. pleuropneumoniae and Passthrough la Water Toshida ( P. multocida ) To determine whether the growth of A and D was inhibited, the minimum inhibitory concentration was measured for the major components of cinnamon essential oil. Cinnamon essential oil consists of more than 90% cinnamaldehyde and the rest is ethyl cinnamate, eugenol (usually on leaves), beta-caryophyllene, Linalool, and methyl chavicol. Cinnamaldehyde was the major component of cinnamon essential oil, which was purchased from Sigma Aldrich (St. Louis, Mo., USA). The measurement was performed by modifying the liquid medium dilution method in the same manner as the measurement of the minimum inhibitory concentration of the cinnamon essential oil. DMSO was used as a negative control and antibiotic ampicillin was used as a positive control. The measurement results are shown in Table 4.
신남알데하이드(cinnamaldehyde)의 액티노바실러스 플루로뉴모니애에 대한 최소저해농도는 1000ppm 이었으며, 나머지 파스투렐라 물토시다 A 및 D 균주들에서는 같은 농도에서 저해활성을 나타내지 않았다. 그리고 신남알데하이드(cinnamaldehyde)의 최소저해농도는 계피 정유의 최소저해농도보다 약 10배 정도 항균활성이 줄어든 것을 확인하였다.The minimum inhibitory concentration of cinnamaldehyde on Actinobacillus fluro- pneumoniae was 1000 ppm, and the rest of the pastelolactone The strains A and D showed no inhibitory activity at the same concentration. The minimum inhibitory concentration of cinnamaldehyde decreased about 10 times the minimum inhibitory concentration of cinnamon essential oil.
위의 결과로 유추해보면 계피 정유의 항균활성은, 주요성분 외에 다른 미량의 성분들과 함께 복합적으로 작용하여야 강한 항균활성을 나타내는 것으로 생각된다.The above results suggest that the antimicrobial activity of cinnamon essential oil has a strong antimicrobial activity when it is combined with other minor components in combination.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130058050A KR20140137529A (en) | 2013-05-23 | 2013-05-23 | Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130058050A KR20140137529A (en) | 2013-05-23 | 2013-05-23 | Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20140137529A true KR20140137529A (en) | 2014-12-03 |
Family
ID=52457271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130058050A KR20140137529A (en) | 2013-05-23 | 2013-05-23 | Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20140137529A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115607536A (en) * | 2022-10-12 | 2023-01-17 | 广东省农业科学院动物卫生研究所 | Application of eucalyptol in preparation of medicament for resisting porcine reproductive and respiratory syndrome virus |
-
2013
- 2013-05-23 KR KR1020130058050A patent/KR20140137529A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115607536A (en) * | 2022-10-12 | 2023-01-17 | 广东省农业科学院动物卫生研究所 | Application of eucalyptol in preparation of medicament for resisting porcine reproductive and respiratory syndrome virus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gómez-García et al. | Antimicrobial activity of a selection of organic acids, their salts and essential oils against swine enteropathogenic bacteria | |
Alagawany et al. | Paenibacillus polymyxa (LM31) as a new feed additive: Antioxidant and antimicrobial activity and its effects on growth, blood biochemistry, and intestinal bacterial populations of growing Japanese quail | |
Yang et al. | Effects of dietary supplementation with essential oils and organic acids on the growth performance, immune system, fecal volatile fatty acids, and microflora community in weaned piglets | |
Du et al. | In vitro antibacterial activity of thymol and carvacrol and their effects on broiler chickens challenged with Clostridium perfringens | |
Redondo et al. | Perspectives in the use of tannins as alternative to antimicrobial growth promoter factors in poultry | |
Elizondo et al. | Effect of tannins on the in vitro growth of Clostridium perfringens | |
KR101618656B1 (en) | Synergetic composition comprising flavouring substances and organic acids and use thereof | |
Horng et al. | Antibacterial activity of Bacillus species-derived surfactin on Brachyspira hyodysenteriae and Clostridium perfringens | |
TWI487488B (en) | Livestock for the prevention and / or treatment of diseases caused by Clostridium bacteria, and anti-Clostridium | |
CN107927416A (en) | A kind of chicken feed addictive and its chicken feed for purifying salmonella | |
Samad | Antibiotics resistance in poultry and its solution | |
Gonzalez-Gil et al. | Yerba mate enhances probiotic bacteria growth in vitro but as a feed additive does not reduce Salmonella Enteritidis colonization in vivo | |
AbdAlHaleem et al. | Effect of dietary oregano supplementation on productive, physiological and immunological performance of broiler chicks | |
Reddy et al. | Antimicrobial resistance and medicinal plant products as potential alternatives to antibiotics in animal husbandry | |
da Cunha et al. | The survival and hepatic and muscle glucose and lactate levels of Rhamdia quelen inoculated with Aeromonas hydrophila and treated with terpinen-4-ol, carvacrol or thymol | |
KR101847686B1 (en) | Composition of animal feed additive comprising pozzolan and use thereof | |
Rattanawut et al. | Production performance, egg quality, and fecal bacterial population of laying ducks fed ration supplemented by bamboo vinegar | |
KR101478110B1 (en) | Ursolic acid having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof | |
Jabri et al. | Effect of Olive leaves extract supplementation in drinking water on zootechnical performances and cecal microbiota balance of broiler chickens | |
KR20130068958A (en) | Staphylococcus pasteuri rsp-1 and its use | |
KR20140137529A (en) | Cinnamon bark essential oil having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof | |
KR101106056B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
KR101478109B1 (en) | Oleanolic acid having anti-bacterial activity against causative bacteria of porcine respiratory disease complex and uses thereof | |
KR101106055B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
Soliman et al. | Effect of dietary oregano supplementation on productive performance and some physiological parameters of Inshas chickens strain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
SUBM | Surrender of laid-open application requested |